New England Biotech Headlines Today is July 04, 2009. All times in Eastern Daylight Time. 07/02/2009 - 04:01 PM Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009 07/01/2009 - 05:00 PM Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA® Pediatrics 07/01/2009 - 08:00 AM Bruker Announces Order for World’s First Commercial 263 GHz EPR Spectrometer from the Helmholtz-Zentrum in Berlin for Solar Energy and Photovoltaic Research Applications 07/01/2009 - 08:00 AM Charles River Announces RMS Succession Plan and Organizational Enhancements 07/01/2009 - 07:30 AM CombinatoRx and Neuromed Sign Merger Agreement 07/01/2009 - 06:00 AM Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. 06/30/2009 - 04:44 PM FDA Approves Feraheme™ to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients 06/30/2009 - 02:30 PM Aushon Technology Chosen for Small Molecule Microarray Research 06/30/2009 - 01:38 PM Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements 06/30/2009 - 11:35 AM NMT Medical Secures $4.0 Million Credit Agreement 06/30/2009 - 09:00 AM New Expanded Atlantis™ Patient-Specific Abutment Compatibility and Material Option for Straumann Implants 06/30/2009 - 08:30 AM Covidien Recognized as Top Medical Devices Innovator 06/30/2009 - 08:00 AM Collegium Pharmaceutical Announces the Sale of AllerNaze™ to Lupin 06/30/2009 - 07:30 AM Dyax Announces Underwriter’s Exercise of Over-allotment Option 06/29/2009 - 06:50 PM FDA Decision on Feraheme NDA Expected Within Next Few Days 1 2   Next »

About Us   |   Contact Us   |   Privacy Statement   |   Terms of Use   |   © Business Wire 2009